 Karen Moulton
Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neovascularization, Pathologic | 2 | 2004 | 280 | 0.340 |
Why?
| | Vascular Remodeling | 2 | 2020 | 153 | 0.310 |
Why?
| | Collagen Type XVIII | 1 | 2004 | 4 | 0.240 |
Why?
| | Vasa Vasorum | 1 | 2004 | 33 | 0.230 |
Why?
| | Capillary Permeability | 1 | 2004 | 137 | 0.220 |
Why?
| | Myofibroblasts | 2 | 2022 | 115 | 0.220 |
Why?
| | Apolipoproteins E | 2 | 2004 | 80 | 0.210 |
Why?
| | Aortic Diseases | 1 | 2004 | 108 | 0.210 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2020 | 409 | 0.210 |
Why?
| | Genes, X-Linked | 1 | 2022 | 16 | 0.200 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 21 | 0.190 |
Why?
| | Atherosclerosis | 1 | 2004 | 342 | 0.180 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 61 | 0.170 |
Why?
| | Tunica Intima | 1 | 1999 | 78 | 0.160 |
Why?
| | Sesquiterpenes | 1 | 1999 | 51 | 0.160 |
Why?
| | PTEN Phosphohydrolase | 1 | 2019 | 140 | 0.160 |
Why?
| | Aortic Valve | 1 | 2022 | 396 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2019 | 233 | 0.140 |
Why?
| | Collagen | 1 | 1999 | 414 | 0.140 |
Why?
| | Gene Expression | 1 | 2022 | 1417 | 0.140 |
Why?
| | Aorta, Thoracic | 1 | 1999 | 257 | 0.130 |
Why?
| | Peptide Fragments | 1 | 1999 | 665 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 2322 | 0.120 |
Why?
| | Fibrosis | 2 | 2020 | 452 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2004 | 2563 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2020 | 1947 | 0.060 |
Why?
| | Mice | 4 | 2020 | 14845 | 0.060 |
Why?
| | Diet, Atherogenic | 1 | 2004 | 6 | 0.060 |
Why?
| | Cholesterol, Dietary | 1 | 2004 | 15 | 0.060 |
Why?
| | Organ Culture Techniques | 1 | 2004 | 140 | 0.060 |
Why?
| | Gene Dosage | 1 | 2004 | 129 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4681 | 0.050 |
Why?
| | Animals | 5 | 2022 | 31567 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2022 | 3861 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2004 | 496 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2022 | 3498 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2004 | 441 | 0.050 |
Why?
| | Skin | 1 | 2004 | 653 | 0.040 |
Why?
| | Actins | 1 | 2022 | 376 | 0.040 |
Why?
| | Swine | 1 | 2022 | 687 | 0.040 |
Why?
| | Angiotensin II | 1 | 2019 | 87 | 0.040 |
Why?
| | Endostatins | 1 | 1999 | 9 | 0.040 |
Why?
| | Cyclohexanes | 1 | 1999 | 22 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 146 | 0.040 |
Why?
| | Arteries | 1 | 2020 | 246 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 236 | 0.040 |
Why?
| | Cell Count | 1 | 1999 | 303 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2004 | 830 | 0.040 |
Why?
| | Aortic Valve Stenosis | 1 | 2022 | 269 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2022 | 1624 | 0.040 |
Why?
| | Cell Division | 1 | 1999 | 754 | 0.040 |
Why?
| | Blotting, Western | 1 | 2019 | 1143 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 1707 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 723 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 541 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1075 | 0.030 |
Why?
| | Male | 4 | 2022 | 55400 | 0.030 |
Why?
| | RNA | 1 | 2019 | 806 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1696 | 0.030 |
Why?
| | Biomarkers | 1 | 2022 | 3397 | 0.020 |
Why?
| | Rats | 1 | 2019 | 4913 | 0.020 |
Why?
| | Radio Waves | 1 | 1991 | 16 | 0.020 |
Why?
| | Atrioventricular Node | 1 | 1991 | 14 | 0.020 |
Why?
| | Electrodes | 1 | 1991 | 99 | 0.020 |
Why?
| | Signal Transduction | 1 | 2022 | 4501 | 0.020 |
Why?
| | Time Factors | 1 | 1999 | 6077 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 1991 | 545 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 1991 | 414 | 0.020 |
Why?
| | Female | 2 | 2022 | 59328 | 0.020 |
Why?
| | Humans | 3 | 2022 | 114050 | 0.010 |
Why?
| | Postoperative Period | 1 | 1991 | 288 | 0.010 |
Why?
| | Equipment Design | 1 | 1991 | 503 | 0.010 |
Why?
| | Heart | 1 | 1991 | 613 | 0.000 |
Why?
| | Myocardium | 1 | 1991 | 911 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1991 | 4392 | 0.000 |
Why?
|
|
Moulton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|